NCT01923597View on ClinicalTrials.gov

Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Diabetic NephropathyHypertension
Interventions
DRUG

Green tea extract

200mg/capsule Administered orally 4 capsules per day For 3 months

Trial Locations (1)

13084-971

Unicamp, Campinas

All Listed Sponsors
lead

University of Campinas, Brazil

OTHER

NCT01923597 - Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. | Biotech Hunter | Biotech Hunter